|
Pharsight Monthly Summary
|
March, 2023
|
Recent happenings in
patent protected
drugs.
|
|
|
Pharsight Monthly Summary
|
March, 2023
|
Recent happenings in
patent protected
drugs.
|
|
|
|
|  |
At a Glance
| |
79
|
new drug
patents
introduced
|
|  |
|
|
|
|  |
Companies who recently
launched drugs
| |
|
|
|  |
Drugs not protected by their main patents
| |
|
|
|  | |  | |  |
Recent patent litigations
|
Patent
|
Petitioner
|
Proceeding Date
|
US10272083
|
Sandoz Inc.
|
2023-02-03
|
US7713947
|
Hopewell Pharma Ventures, Inc. et al.
|
2023-01-23
|
US8377903
|
Hopewell Pharma Ventures, Inc. et al.
|
2023-01-23
|
US7713947
|
TWi Pharmaceuticals, Inc.
|
2022-10-14
|
US8377903
|
TWi Pharmaceuticals, Inc.
|
2022-10-14
|
US11110087
|
Dr. Reddy's Laboratories, Inc. et al.
|
2022-10-14
|
US7041786
|
MSN Laboratories Private Ltd.
|
2022-10-12
|
|
|
| See in detail |
|  | What's new on Pharsight! | Patent families: Uncovering the Protected Places! A patent family is like a group of siblings, all protecting the same invention or product under different patent offices. To launch a generic drug, it's important to know all the patents in the family, when they'll grow up and leave (expire), and any legal drama they may have. It can help you with simple questions like I have a generic in the US, but can I launch the same in India? This info affects when you can launch your generic, how successful it will be, and who your competitors will be. So, think of it as doing a background check on your future market before diving in! Get ready for some serious legal battles! We have a special page all about drugs that are protected by patents which act as a competitive advantage. To bypass this protection, oftentimes these patents are argued in court. The outcome can affect when generic versions of the drug become available and how much they cost. Check out recent patent litigations |
|
|
|
|  | |
© 2023 GreyB Research |
|
|